Company Filing History:
Years Active: 2010-2020
Title: Shingo Nakatani: Innovator in Pharmaceutical Chemistry
Introduction
Shingo Nakatani is a prominent inventor based in Osaka, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that target specific medical conditions. With a total of 9 patents to his name, Nakatani's work has the potential to impact the treatment of various diseases.
Latest Patents
Nakatani's latest patents include innovative compounds that serve as inhibitors for critical biological factors. One notable invention is a pyrimidinone and its derivatives that inhibit factor XIa. This invention provides compounds of the general formula (I), which are useful in the prevention and therapy of thromboembolic diseases. Another significant patent is a tetrahydrocarboline derivative aimed at providing a drug with inhibitory activity on ENPP2. This compound is particularly beneficial for patients with urinary excretion disorders, offering a new therapeutic option where existing drugs may fall short.
Career Highlights
Throughout his career, Shingo Nakatani has worked with notable companies in the pharmaceutical industry, including Ono Pharmaceutical Co., Ltd. and Ono Pharmaceuticals Co., Ltd. His experience in these organizations has allowed him to refine his expertise and contribute to groundbreaking research and development in drug formulation.
Collaborations
Nakatani has collaborated with esteemed colleagues such as Akira Ohata and Tetsuya Sugiyama. These partnerships have fostered a collaborative environment that enhances innovation and drives forward the development of new therapeutic agents.
Conclusion
Shingo Nakatani's contributions to pharmaceutical chemistry exemplify the impact of innovative thinking in medicine. His patents reflect a commitment to addressing unmet medical needs and improving patient outcomes.